COVID-19 in Pregnancy
On this page
Direct answer
Pregnant women with symptomatic COVID-19 run a higher risk of intensive care admission, invasive ventilation and death than non-pregnant women of the same age, and infection raises preterm birth, stillbirth (particularly with the Delta variant) and pre-eclampsia rates — yet vertical transmission remains rare, around 1-2 per cent, mostly near or after delivery. Management follows severity tiers: mild disease is home care with low-dose aspirin continuation where indicated and awareness of red flags; moderate-to-severe disease needs hospitalisation with oxygen, corticosteroids (dexamethasone for the mother's lungs, which conveniently also matures the fetal lungs after 24 weeks), remdesivir where indicated, and prophylactic low-molecular-weight heparin, since pregnancy and COVID-19 are both prothrombotic. Delivery timing is obstetric, not virological — caesarean is not mandated for COVID-19, delayed cord clamping and breastfeeding with masking are supported, and vaccination in pregnancy, including boosters, is safe and effective, with no signal of adverse pregnancy outcome.
What you must remember
- Risk arithmetic: pregnancy itself raises the odds of severe COVID-19 — ICU admission, ventilation and maternal death — with obesity, diabetes, hypertension and age over 35 compounding; the Delta wave (India 2021) showed the steepest maternal mortality spike, and subsequent variants have been milder.
- Fetal and obstetric burden: preterm birth (largely iatrogenic for maternal compromise), higher stillbirth with severe disease, possible pre-eclampsia association, and growth concerns — hence increased fetal surveillance after recovery from significant illness.
- Vertical transmission facts: rare (about 1-2 per cent of third-trimester infections), almost exclusively around delivery; placental infection is described but congenital infection syndrome is not established — the answer to "can COVID cause congenital anomalies" remains no consistent signal.
- Drug logic: dexamethasone 6 mg twice daily for ten days or until discharge if oxygen-requiring (dual benefit: maternal lungs and fetal lung maturity after 24 weeks; in the pre-Delta mild-disease patient, steroids were not given solely for COVID); remdesivir for hypoxia; LMWH thromboprophylaxis for admitted patients; tocilizumab in selected severe cases; avoid NSAID excess in the third trimester.
- Delivery decisions: mode and timing follow obstetric indication — spontaneous labour with COVID is not an indication for caesarean; aim to avoid delaying indicated delivery for test positivity; the second stage may be shortened if the mother is hypoxic; and staff use airborne precautions for suspected cases.
- Postnatal and feeding: breastfeeding is encouraged with mask and hand hygiene — separation of mother and baby is not recommended where both are stable; the WHO position that the benefits outweigh the risks remains the quoted line.
- Vaccination doctrine: COVID-19 vaccines in pregnancy are safe (no signal for miscarriage, anomaly, stillbirth or fetal growth problems in surveillance data) and effective, recommended in any trimester in India's national guidance, including for lactating women — the question "when in pregnancy can she be vaccinated" answers "any time".
- Indian programme anchor: vaccination of pregnant women was formally added to India's national programme in July 2021 after the Delta-wave experience — a quotable current-programme fact — with MOHFW guidance on home isolation, referral pathways and dedicated obstetric HDU beds.
A typical exam case
A 31-year-old at 34 weeks, unvaccinated, presents with five days of fever, cough and breathlessness; saturation is 92 per cent on room air, and she is tachypnoeic at 26. The walk-through: admit with oxygen by face mask to hold saturation above 94 per cent, start dexamethasone (covering both her lungs and fetal maturity), begin prophylactic LMWH, consider remdesivir within its window, and position her semi-recumbent and later left-tilted for aortocaval relief. Monitor with oxygen saturation, respiratory rate and repeated inflammatory markers; monitor the fetus with cardiotocography once she is stabilised. Delivery is not immediate — improve the mother first — but progressive oxygen failure moves toward delivery at 34-37 weeks as both therapy for her and safety for the baby, by a mode dictated by obstetric factors with full airborne precautions. Postnatally: mother and baby room together if she is stable, breastfeed with mask, continue LMWH, and discharge with vaccination counselling — after recovery is an acceptable moment to complete her primary series. The tiered logic — oxygen, steroids, anticoagulation, timed delivery — is the mark scheme.
How the exam frames it
Stems cluster around discriminations rather than virology. "Which drug is given for oxygen-requiring COVID in pregnancy" — dexamethasone (with the fetal-maturity bonus noted). "Is caesarean indicated for COVID-positive labour" — no, obstetric indications govern. "Rate of vertical transmission" — about 1-2 per cent, mostly peripartum. "Can she breastfeed" — yes, with mask and hygiene. "When can she be vaccinated" — any trimester; a stem describing a first-trimester vaccination request tests whether the candidate wrongly defers it. The Indian Delta-wave experience supplies the applied layer: unvaccinated multipara with rapid hypoxia and intrauterine death was the 2021 archetype, and national-programme facts (pregnant women included in vaccination from July 2021) carry the current-affairs mark. Finally, remember thromboprophylaxis — the combination of pregnancy, immobility, and severe infection is the classic triple hit examiners use to test LMWH prescription.
Frequently asked questions
Does pregnancy increase the risk of severe COVID-19?
Yes — symptomatic pregnant women face higher rates of intensive care admission, ventilation and maternal death than non-pregnant peers, compounded by obesity, diabetes and advanced maternal age.
Can COVID-19 pass from mother to fetus in utero?
Rarely — vertical transmission occurs in only about 1-2 per cent, almost always around delivery, with no established congenital anomaly syndrome.
Which COVID therapies are used in pregnant women?
Oxygen as needed, dexamethasone for hypoxia (also accelerating fetal lung maturity after 24 weeks), remdesivir in selected cases, and prophylactic low-molecular-weight heparin for thromboprophylaxis.
Is caesarean delivery required for COVID-19 positivity?
No — mode and timing of delivery follow standard obstetric indications, with precautions and possible shortening of the second stage if the mother is hypoxic.
Are COVID-19 vaccines safe in pregnancy?
Yes — surveillance shows no increase in miscarriage, congenital anomaly or stillbirth, and vaccination is recommended in any trimester, including for lactating women.